2Da Silva CH, Giugliani ER. Consumption of medicines among adolescent students: a concern. J Pediatr(Rio J),2004,80:326-332.
3Komoriya K, Hoshide S, Takeda K, et al. Pharmacokinetics and pharmacodynamics of febuxostat (TMX-67), a non-purine selective inhibitor of xanthine oxidase/xanthine dehydrogenase (NPSIXO) in patients with gout and/or hyperuricemia. Nucleosides Nucleotides Nucleic Acids,2004,23:1119-1122.
4Kong LD, Cai Y, Huang WW, et al. Inhibition of xanthine oxidase by ome Chinese medicinal plants used to treat gout. J Ethnopharmacol,2000,73(1-2): 199-207.
5Kong L, Zhou J, Wen Y, et al. Aesculin possesses potent hypouricemic action in rodents but is devoid of xanthine oxidase/dehydrogenase inhibitory activity. Planta Med,2002,68:175-178.
6KongLD, YangC, GeF,etal. AChineseherbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J Ethnopharmacol,2004,93:325-330.
7Mukhin Ⅳ, Ignatenko GA, Nikolenko VY. Dyshormonal disorders in gout: experimental and clinical studies. Bull Exp Biol Med,2002,133:491-493.
8Tausche AK,Richter K, Grassler A,et al.Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option. Ann Rheum Dis, 2004, 63: 1351-1352.
9Arromdee E, Michet CJ, Crowson CS, et al. Epidemiology of gout: is the incidence rising? J Rheumatol,2002,29:2403-2406.
10Kamienski M. Gout: not just for the rich and famous! Everyman's disease. Orthop Nurs,2003,22:16-20.
